Alacare Competitors or Alternatives

Alacare's top competitors include VITAS, Amedisys and Pathways Home Health and Hospice.

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

Alacare's company profile

Susan Beard Brouillette

CEO

90/100
500 - 1,000
$0
$100M - 500M
1
Alacare's Competitor - VITAS logo

Nicholas M Westfall

President & CEO

41/100
10,000 - 50,000
- -
$100M - 500M
2
Alacare's Competitor - Amedisys logo

Richard Ashworth

President & CEO

66/100
20,000
- -
$2.3B
3
Alacare's Competitor - Pathways Home Health and Hospice logo

CEO

- -
350
- -
$12M
4
Alacare's Competitor - NHPCO logo

Edo Banach

President & CEO

90/100
100 - 250
- -
$5M - 25M
5
Alacare's Competitor - Visiting Nurse Health System logo

Dorothy Davis

President & CEO

88/100
380
$2M
$65M

Alacare VS VITAS

VITAS is perceived as one of Alacare's biggest rivals. VITAS was founded in 1978 in Miami, Florida. VITAS is in the Health Care Services field. VITAS generates $321M more revenue than Alacare.

Alacare VS Amedisys

Amedisys is Alacare's #2 rival. Amedisys is a Public company that was founded in 1982 in Baton Rouge, Louisiana. Amedisys competes in the Health Care Services field. Compared to Alacare, Amedisys has 19,100 more employees.

Alacare VS Pathways Home Health and Hospice

Pathways Home Health and Hospice is one of Alacare's top competitors. Pathways Home Health and Hospice's headquarters is in Sunnyvale, California, and was founded in 1977. Like Alacare, Pathways Home Health and Hospice also operates in the Health Care Equipment & Services industry. Pathways Home Health and Hospice generates 10% of Alacare's revenue.

Frequently Asked Questions about Alacare

  1. Who are Alacare's top competitors?

    Alacare's top 3 competitors are VITAS, Amedisys, Pathways Home Health and Hospice.
  2. Who is similar to Alacare?

    VITAS is the most similar to Alacare. Amedisys and Pathways Home Health and Hospice are also similar to Alacare.
  1. Are Alacare and VITAS competitors?

    Yes, VITAS is one of Alacare’s top competitors.